Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Fleseriu

Showing results (181-190 of 268) with videos related to

Pageof 27
Sort By:
Pituitary|January 13, 2022
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experienceRoberto Salvatori, Pietro Maffei, Susan M Webb, et al.
Nature Reviews. Endocrinology|June 6, 2024
Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and managementDaniela Esposito, Cesar Luiz Boguszewski, Annamaria Colao, et al.
Endocrine|May 23, 2016
Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide studyJames W Findling, Maria Fleseriu, John Newell-Price, et al.
Pituitary|December 1, 2025
Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient surveyHidenori Fukuoka, Andrea Glezer, Niki Karavitaki, et al.
Pituitary|November 4, 2023
Consensus on criteria for acromegaly diagnosis and remissionAndrea Giustina, Nienke Biermasz, Felipe F Casanueva, et al.
Pituitary|January 1, 2022
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United StatesMaria Fleseriu, Ariel Barkan, Maria Del Pilar Schneider, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2020
EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive ProlactinomasOdelia Cooper, Vivien S Bonert, Jeremy Rudnick, et al.
Pituitary|December 5, 2023
Correction: consensus on criteria for acromegaly diagnosis and remissionAndrea Giustina, Nienke Biermasz, Felipe F Casanueva, et al.
Journal of Clinical Medicine|March 25, 2022
Clinical Study and Systematic Review of Pituitary Microadenomas vs. Macroadenomas in Cushing's Disease: Does Size Matter?Amit Akirov, Ilan Shimon, Maria Fleseriu, et al.
Pituitary|October 11, 2022
Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2)Maria Fleseriu, Beverly M K Biller, Jérôme Bertherat, et al.
Pageof 27

Showing results (181-190 of 268) with videos related to

Sort By:
Pageof 27
Pituitary|January 13, 2022
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experienceRoberto Salvatori, Pietro Maffei, Susan M Webb, et al.
Nature Reviews. Endocrinology|June 6, 2024
Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and managementDaniela Esposito, Cesar Luiz Boguszewski, Annamaria Colao, et al.
Endocrine|May 23, 2016
Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide studyJames W Findling, Maria Fleseriu, John Newell-Price, et al.
Pituitary|December 1, 2025
Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient surveyHidenori Fukuoka, Andrea Glezer, Niki Karavitaki, et al.
Pituitary|November 4, 2023
Consensus on criteria for acromegaly diagnosis and remissionAndrea Giustina, Nienke Biermasz, Felipe F Casanueva, et al.
Pituitary|January 1, 2022
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United StatesMaria Fleseriu, Ariel Barkan, Maria Del Pilar Schneider, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2020
EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive ProlactinomasOdelia Cooper, Vivien S Bonert, Jeremy Rudnick, et al.
Pituitary|December 5, 2023
Correction: consensus on criteria for acromegaly diagnosis and remissionAndrea Giustina, Nienke Biermasz, Felipe F Casanueva, et al.
Journal of Clinical Medicine|March 25, 2022
Clinical Study and Systematic Review of Pituitary Microadenomas vs. Macroadenomas in Cushing's Disease: Does Size Matter?Amit Akirov, Ilan Shimon, Maria Fleseriu, et al.
Pituitary|October 11, 2022
Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2)Maria Fleseriu, Beverly M K Biller, Jérôme Bertherat, et al.
Pageof 27